Prevalence and Associated Factors of Thyroid Nodules Among 52,003 Chinese ‘Healthy’ Individuals in Beijing: A Retrospective Cross-Sectional Study

References

• Schlumberger MJ, Filetti S, Hay ID. Nontoxic goiter and thyroid neoplasia. In: Williams’ Textbook of Endocrinology. WB Saunders Company; 2003.
   Google Scholar
• Gharib H, Papini E, Paschke R, et al.; AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract. 2010;16(3):468–475. doi:10.4158/EP.16.3.468
   PubMedGoogle Scholar
• Teng W, Xing X, Tong N, Weng J, Shi L. Epidemiological survey of thyroid diseases in 10 cities of China. collecting paper of the ninth national symposium on endocrinology. Thyroid. 2010;30(4):568–579. Chinese.
   Google Scholar
• Cooper DS, Doherty GM, Haugen BR, et al.; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214. doi:10.1089/thy.2009.0110
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ; US Preventive Services Task Force. Screening for thyroid cancer: US preventive services task force recommendation statement. JAMA. 2017;317(18):1882–1887. doi:10.1001/jama.2017.4011
   PubMed Web of Science ®Google Scholar
• Hoang JK, Nguyen XV. Understanding the risks and harms of management of incidental thyroid nodules: a review. JAMA Otolaryngol Head Neck Surg. 2017;143(7):718–724. doi:10.1001/jamaoto.2017.0003
   PubMed Web of Science ®Google Scholar
• Grani G, Lamartina L, Ascoli V, et al. Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: toward the “Right” TIRADS. J Clin Endocrinol Metab. 2019;104(1):95–102. doi:10.1210/jc.2018-01674
   PubMed Web of Science ®Google Scholar
• Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006;354(26):2783–2793. doi:10.1056/NEJMoa054022
   PubMed Web of Science ®Google Scholar
• Reiners C, Wegscheider K, Schicha H, et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid. 2004;14(11):926–932. doi:10.1089/thy.2004.14.926
   PubMed Web of Science ®Google Scholar
• Katagiri R, Yuan X, Kobayashi S, Sasaki S. Effect of excess iodine intake on thyroid diseases in different populations: a systematic review and meta-analyses including observational studies. PLoS One. 2017;12(3):e0173722. doi:10.1371/journal.pone.0173722
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453. doi:10.1016/S0140-6736(07)61602-X
   PubMed Web of Science ®Google Scholar
• Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3(1):17. doi:10.1186/1751-0473-3-17
   PubMedGoogle Scholar
• Liu Y, Lin Z, Sheng C, et al. The prevalence of thyroid nodules in northwest China and its correlation with metabolic parameters and uric acid. Oncotarget. 2017;8(25):41555–41562. doi:10.18632/oncotarget.14720
   PubMedGoogle Scholar
• Feng S, Zhang Z, Xu S, et al. The prevalence of thyroid nodules and their association with metabolic syndrome risk factors in a moderate iodine intake area. Metab Syndr Relat Disord. 2017;15(2):93–97. doi:10.1089/met.2016.0077
   PubMed Web of Science ®Google Scholar
• Tang Y, Gao GL, GSh LI. Characteristics of thyroid nodules in Weihai city. China Practical Med. 2010;05(31):54–55. Chinese.
   Google Scholar
• Xu LF, Liu DT, Tian HY, Yang YH, Wang Y. An analysis of thyroid nodule diseases and related factors in healthy population in Shijiazhuang city. Hebei Med J. 2012;34(9):1399–1400. Chinese.
   Google Scholar
• Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007;36(3):707–735. doi:10.1016/j.ecl.2007.04.009
   PubMed Web of Science ®Google Scholar
• Kang HW, No JH, Chung JH, et al. Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid. 2004;14(1):29–33. doi:10.1089/105072504322783812
   PubMed Web of Science ®Google Scholar
• Vander JB. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69(3):537–540. doi:10.7326/0003-4819-69-3-537
   PubMed Web of Science ®Google Scholar
• Lean AD, Ferland L, Drouin J, Kelly PA, Labrie F. Modulation of pituitary thyrotropin releasing hormone receptor levels by estrogens and thyroid hormones. Endocrinology. 1977;100(6):1496–1504. doi:10.1210/endo-100-6-1496
   PubMed Web of Science ®Google Scholar
• Franklyn JA, Wood DF, Balfour NJ, Ramsden DB, Docherty K, Sheppard MC. Modulation by oestrogen of thyroid hormone effects on thyrotropin gene expression. J Endocrinol. 1987;115(1):53–59. doi:10.1677/joe.0.1150053
   PubMed Web of Science ®Google Scholar
• Yane K, Kitahori Y, Konishi N, et al. Expression of the estrogen receptor in human thyroid neoplasms. Cancer Lett. 1994;84(1):59–66. doi:10.1016/0304-3835(94)90358-1
   PubMed Web of Science ®Google Scholar
• Del Senno L, Degli Uberti E, Hanau S, Piva R, Rossi R, Trasforini G. In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids. Mol Cell Endocrinol. 1989;63(1–2):67–74. doi:10.1016/0303-7207(89)90082-8
   PubMed Web of Science ®Google Scholar
• Furlanetto TW, Nguyen LQ, Jameson JL. Estradiol increases proliferation and down-regulates the sodium/Iodide symporter gene in FRTL-5 cells. Endocrinology. 1999;140(12):5705–5711. doi:10.1210/endo.140.12.7197
   PubMed Web of Science ®Google Scholar
• Chang X, Wang Y, Songbo F, et al. The detection of thyroid nodules in prediabetes population and analysis of related factors. Risk Manag Healthc Policy. 2021;14:4875–4882. doi:10.2147/RMHP.S337526
   PubMed Web of Science ®Google Scholar
• Quang Tran N, Bao Hoang LE, Khanh Hoang C, et al. Prevalence of thyroid nodules and associated clinical characteristics: findings from a large sample of people undergoing health checkups at a university hospital in Vietnam. Risk Manag Healthc Policy. 2023;16:899–907. doi:10.2147/RMHP.S410964
   PubMed Web of Science ®Google Scholar
• Moon JH, Hyun MK, Lee JY, et al. Prevalence of thyroid nodules and their associated clinical parameters; a large-scale, multicenter-based health checkup study. Korean J Intern Med. 2018;33(4):753–762. doi:10.3904/kjim.2015.273
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu C, Chen Y, et al. The association of thyroid nodules with metabolic status: a cross-sectional SPECT-China study. Int J Endocrinol. 2018;2018:6853617. doi:10.1155/2018/6853617
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi:10.1089/thy.2015.0020
   PubMed Web of Science ®Google Scholar
• Durante C, Hegedüs L, Czarniecka A, et al. European thyroid association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. 2023;12(5):e230067. doi:10.1530/ETJ-23-0067
   PubMed Web of Science ®Google Scholar